Blocking C-MET and BRAF pathways in melanoma to overcome resistance in mouse models
Clemens Krepler, MD of the Wistar Institute, Philadelphia, PA, discusses resistance mechanisms in BRAF-mutated melanoma in mouse models. The tumors develop a very strong growth signal through the BRAF...
Author: VJOncology
Added: 09/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 12, 2016 Category: Cancer & Oncology Source Type: podcasts
The future of tyrosine kinase inhibitors for melanoma and open questions
Axel Hauschild, MD, PhD of University Hospital Schleswig-Holstein, Kiel, Germany, gives an overview of his talk on the future of tyrosine kinase inhibiton for melanoma at the 2016 World Congress on Ca...
Author: VJOncology
Added: 09/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 12, 2016 Category: Cancer & Oncology Source Type: podcasts
The current status and future of vaccinations for melanoma
Brigitte Drno, MD, PhD of the University Hospital of Nantes, Nantes, France discusses vaccinations for melanoma and the decrease in the number of clinical trials being carried out. She explains the d...
Author: VJOncology
Added: 09/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 12, 2016 Category: Cancer & Oncology Source Type: podcasts
Results from trial of vemurafenib and cobimetinib and LDH as a predictive marker for outcome in BRAF-mutated melanoma
Axel Hauschild, MD, PhD of University Hospital Schleswig-Holstein, Kiel, Germany, gives an overview of his talk on vemurafenib and cobimetinib for BRAF-mutated metastatic melanoma held at the 2016 Wor...
Author: VJOncology
Added: 09/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 12, 2016 Category: Cancer & Oncology Source Type: podcasts
Why the incidence of skin cancer increased in Central Europe and preventative measures
Petr Arenberger, MD, PhD, DSc, MBA of Charles University, Prague, Czech Republic discusses skin cancer in Central Europe at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of th...
Author: VJOncology
Added: 09/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 12, 2016 Category: Cancer & Oncology Source Type: podcasts
Cell cycle-dependent resistance or sensitivity to drugs and the importance of the MITF gene in melanoma
Nikolas Haass, MD, PhD of the University of Queensland, Brisbane, Australia discusses cell cycle-dependent drug resistance or sensitivity in melanoma. Prof. Haass discusses a recent article published ...
Author: VJOncology
Added: 09/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 12, 2016 Category: Cancer & Oncology Source Type: podcasts
How imaging techniques used to assess response in skin cancer are changing
Marius Erik Mayerhfer, MD, PhD of the Medical University of Vienna, Vienna, Austria discusses changes in the imaging methods used to assess response for melanoma. The RECIST criteria is the most freq...
Author: VJOncology
Added: 09/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 12, 2016 Category: Cancer & Oncology Source Type: podcasts
